Moderna was a major player in the race to develop a vaccine for COVID-19. Now, according to a recent Engadget article, the company is using the same mRNA-based technology to combat the seasonal flu. The company announced last Wednesday that it has begun human trials as part of a Phase 1/2 clinical study.
Moderna’s mRNA Flu Vaccine Enters Trials
The same technology behind the COVID-19 vaccine looks to take on normal seasonal bugs next.
Jul 16, 2021
Recommended
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
